Prometrium Cost in New Mexico 2026: Cash Price, Insurance, Medicaid, and Compounding Options

What Does Prometrium Actually Cost in New Mexico in 2026?

Prometrium's sticker price and what patients actually pay are two very different numbers. The Solvay/AbbVie manufacturer list price is approximately $180 per month for a 30-capsule supply of 200 mg capsules. At New Mexico retail pharmacies in 2026, cash-paying patients who use a prescription discount card typically pay around $45 per month. Patients who qualify for compounded micronized progesterone from a licensed 503A pharmacy pay roughly $25 per month.

Manufacturer List Price vs. Actual Cash Price

The $180 list price is what appears on the drug before any rebates, coupons, or negotiations. No cash-paying patient in New Mexico needs to pay that amount. Generic micronized progesterone capsules (the bioequivalent of Prometrium) are available at most major New Mexico pharmacy chains and typically fall in the $40 to $55 per month range without insurance when a GoodRx-style coupon is applied.

Prometrium itself is oral micronized progesterone, FDA-approved since 1998 for two indications: prevention of endometrial hyperplasia in non-hysterectomized postmenopausal women receiving conjugated estrogens, and secondary amenorrhea. The FDA Prometrium prescribing information confirms the 200 mg nightly dose for endometrial protection and the 400 mg nightly dose (for 10 days) for secondary amenorrhea.

Price Comparison Across New Mexico Pharmacies

Prices vary by pharmacy and zip code within New Mexico. Urban pharmacies in Albuquerque and Santa Fe tend to show tighter competition. Rural pharmacies near Farmington, Roswell, or Las Cruces may have slightly higher cash prices. Running a GoodRx or Blink Health search before filling will show the lowest price at pharmacies within a given radius. The $45 per month figure is a reasonable middle estimate for 2026 across the state.

The PEPI trial (Postmenopausal Estrogen/Progestin Interventions, published in JAMA 1995, N=875) established that micronized progesterone produced the most favorable lipid profile among all progestogen regimens tested, including medroxyprogesterone acetate (MPA). That pharmacological distinction is one reason clinicians and patients prefer Prometrium or its generic over older synthetic progestins, even at a higher cost.

Does New Mexico Medicaid Cover Prometrium?

New Mexico Medicaid (Centennial Care) does not cover Prometrium or generic micronized progesterone for the indication of endometrial protection in hormone replacement therapy as of 2026. This is a significant gap for lower-income postmenopausal women in a state where roughly 43% of residents are enrolled in Medicaid or CHIP according to KFF state health coverage data.

Why Medicaid Excludes It

State Medicaid programs negotiate their own preferred drug lists (PDLs). New Mexico Centennial Care's PDL favors medroxyprogesterone acetate (Provera generics) as the preferred progestogen. Micronized progesterone is classified as non-preferred and requires prior authorization that is rarely approved for hormone therapy indications. The clinical evidence supporting micronized progesterone's tolerability advantage, including data from the PEPI trial, has not yet translated into preferred formulary status in this state.

Potential Workarounds for Medicaid Patients

Patients on New Mexico Medicaid who need micronized progesterone have a few realistic options. First, a prescriber may submit a prior authorization citing medical necessity, particularly if the patient has documented intolerance to MPA (depression, libido changes, breast tenderness). Second, compounded micronized progesterone from a 503A pharmacy may be obtained at out-of-pocket cost of roughly $25 per month, which many patients find manageable. Third, patient assistance programs from AbbVie exist for uninsured or underinsured patients, though Medicaid enrollment can complicate eligibility. Patients should contact AbbVie directly at 1-800-633-9110 to check current program terms.

The FDA's guidance on compounded drug products distinguishes between 503A pharmacies (patient-specific compounding) and 503B outsourcing facilities. Medicaid generally does not reimburse compounded preparations, so cost is fully out-of-pocket either way.

Is Compounded Micronized Progesterone Legal in New Mexico?

Yes. Compounded micronized progesterone is legal in New Mexico when prepared by a pharmacy operating under Section 503A of the Federal Food, Drug, and Cosmetic Act. These pharmacies compound on a patient-specific basis following a valid prescription from a licensed prescriber. The FDA's 503A compounding framework requires that the compounded preparation is not a copy of a commercially available product unless there is a documented clinical difference, such as a different delivery form or dose strength.

How 503A Pharmacies Operate in New Mexico

New Mexico's pharmacy practice is governed by the New Mexico Board of Pharmacy, which aligns with federal 503A requirements. A licensed 503A pharmacy in New Mexico may legally compound micronized progesterone capsules, topical creams, or vaginal suppositories for individual patients. This matters clinically because oral capsule formulations are the best-studied form, but some patients tolerate vaginal micronized progesterone better, particularly those who experience next-day sedation from oral dosing.

The New Mexico Board of Pharmacy maintains a list of licensed compounding pharmacies in-state. Telehealth prescribers operating in New Mexico can send prescriptions to any licensed NM 503A pharmacy or to an out-of-state 503A pharmacy licensed to ship into New Mexico.

Compounded vs. FDA-Approved: What the Science Says

The FDA-approved Prometrium product and compounded micronized progesterone both use the same active pharmaceutical ingredient: micronized progesterone. The key difference is that Prometrium's peanut oil-based capsule has undergone full bioavailability testing. Compounded preparations vary in excipients and have not undergone the same standardized bioavailability testing. A 2018 Menopause journal position statement from the Menopause Society notes that compounded bioidentical hormones are not equivalent to FDA-approved products in terms of quality assurance, though the active molecule is identical.

For patients who cannot afford Prometrium or its generic, compounded micronized progesterone at roughly $25 per month is a reasonable clinical compromise when prescribed by a knowledgeable provider and filled at a reputable 503A pharmacy.

Which Insurance Plans Cover Prometrium in New Mexico?

Coverage for Prometrium among commercial insurers in New Mexico is inconsistent. Most major plans, including Blue Cross Blue Shield of New Mexico, Presbyterian Health Plan, and Molina Healthcare commercial products, list generic micronized progesterone on their formularies at Tier 2 or Tier 3. Brand-name Prometrium is typically Tier 3 or Tier 4, meaning higher cost-sharing.

Tier Placement and What It Means for Your Wallet

A Tier 2 generic copay in New Mexico commercial plans averages $15 to $35 per 30-day fill. A Tier 3 placement often means 20% to 50% coinsurance after the deductible, which can push monthly cost above $60 depending on the plan. The AbbVie savings card reduces the copay for commercially insured patients to as low as $0 to $15 per fill, subject to program limits. The savings card is not valid for government-funded insurance (Medicare, Medicaid, TRICARE).

Medicare Part D Coverage in New Mexico

Generic micronized progesterone appears on many New Mexico Medicare Part D formularies, though tier placement varies by plan. During the deductible phase (up to $590 in 2026), patients pay full negotiated price, typically $40 to $60 per month for the generic. After meeting the deductible, cost-sharing drops substantially. Patients can use the Medicare Plan Finder to compare Part D plans in New Mexico by formulary tier and estimated annual drug cost.

The 2022 North American Menopause Society (NAMS) position statement states that for postmenopausal women with a uterus, a progestogen must be added to systemic estrogen to protect the endometrium, and that micronized progesterone is associated with a more favorable risk profile for breast cancer and cardiovascular outcomes compared to synthetic progestins. That guideline endorsement creates a strong medical necessity argument for insurance prior authorization appeals.

Can I Get a Prometrium Prescription via Telehealth in New Mexico?

Yes. Telehealth prescribing of Prometrium and generic micronized progesterone is legal in New Mexico in 2026. Prescribers licensed in New Mexico may conduct synchronous video visits and issue controlled and non-controlled prescriptions electronically. Prometrium is not a controlled substance, so no DEA telemedicine registration or in-person visit requirement applies.

How Telehealth Visits Work for HRT in New Mexico

A telehealth visit for hormone therapy in New Mexico typically takes 20 to 40 minutes. The prescriber reviews the patient's symptom history, relevant medical history (including cardiovascular risk factors, prior hormone-sensitive cancers, and thrombotic history), and any recent lab or imaging results. Baseline labs before starting HRT often include FSH, estradiol, and a lipid panel, though specific lab requirements vary by provider protocol.

After the visit, the prescription is sent electronically to a pharmacy of the patient's choice. The FDA prescribing information for Prometrium specifies that the 200 mg capsule be taken at bedtime due to sedative effects from progesterone's conversion to allopregnanolone, a positive GABA-A modulator. That instruction is clinically important: patients who take it in the morning often report next-day cognitive fog.

Telehealth Platforms Serving New Mexico

Several telehealth platforms operate in New Mexico and prescribe Prometrium or its generic as part of broader HRT programs. HealthRX connects New Mexico patients with licensed NM providers who can evaluate hormone therapy candidacy, prescribe oral micronized progesterone, and coordinate with local or mail-order pharmacies. Visits are available within days rather than weeks, which matters for patients managing peri-menopausal symptoms.

How to Get the Lowest Prometrium Price in New Mexico: A Practical Checklist

Getting the lowest price requires checking multiple channels before filling each prescription. Prices shift quarterly as pharmacy benefit managers renegotiate rates.

The following framework reflects the HealthRX clinical team's standard approach for New Mexico patients in 2026:

Step 1. Check GoodRx, RxSaver, and Blink Health for the generic (search "micronized progesterone 200 mg 30 capsules") at pharmacies within your zip code. The lowest price in most NM cities is $35 to $55.

Step 2. Apply the AbbVie savings card if you have commercial insurance. Download it at myabbvie.com or ask your prescriber for a printed card. The card may reduce your copay to $0 for eligible patients.

Step 3. Ask about 90-day supply pricing. Mail-order pharmacies and some retail chains offer a 90-day supply at two months' cost. That alone drops the effective monthly price by 33%.

Step 4. Request a 503A compounding pharmacy quote. A licensed NM compounding pharmacy will typically quote $20 to $30 per month for oral micronized progesterone capsules. Get the quote in writing before transferring your prescription.

Step 5. Check AbbVie patient assistance. If your household income is at or below 600% of the federal poverty level and you are uninsured or underinsured, you may qualify for free or reduced-cost Prometrium through the AbbVie Patient Assistance Foundation. Apply at myabbvie.com or call 1-800-222-6885.

The National Institutes of Health MedlinePlus drug database confirms that micronized progesterone (Prometrium) is available in 100 mg and 200 mg oral capsules and is prescribed for both secondary amenorrhea and endometrial protection in postmenopausal women on estrogen therapy.

Clinical Context: Why Micronized Progesterone Matters for Safety

The choice between micronized progesterone and synthetic progestins is not merely a cost question. The PEPI trial (JAMA 1995, N=875) found that women on conjugated estrogens plus cyclic micronized progesterone had HDL cholesterol levels similar to those on estrogen alone, while women on conjugated estrogens plus MPA experienced significant HDL suppression. That lipid profile difference has downstream implications for cardiovascular risk.

Breast Cancer Risk Data

The E3N cohort study (published in Breast Cancer Research and Treatment, 2008, N=80,377 French women) found that postmenopausal women using estrogen plus micronized progesterone had no significant increase in breast cancer risk (relative risk 1.00, 95% CI 0.83 to 1.22), while those using estrogen plus synthetic progestins showed elevated risk. This distinction drives many oncologist-reviewed HRT protocols toward micronized progesterone as the preferred progestogen.

Sleep and Mood Benefits

Oral micronized progesterone produces sedative effects through its metabolite allopregnanolone, which potentiates GABA-A receptors. A randomized trial published in Menopause (2012) found that 300 mg oral micronized progesterone improved self-reported sleep quality in postmenopausal women compared to placebo. Some patients view this as a clinical benefit rather than a side effect, particularly those with concurrent insomnia.

Who Should Not Take Prometrium

The FDA prescribing label lists peanut allergy as a contraindication because Prometrium capsules contain peanut oil. Patients with known peanut allergy who need micronized progesterone should be prescribed a compounded formulation using a different oil base (typically sunflower or sesame oil) or a vaginal micronized progesterone preparation. Prometrium is also contraindicated in patients with undiagnosed abnormal uterine bleeding, active thromboembolic disorders, and known or suspected breast or genital malignancy.

Dosing Reference for New Mexico Prescribers and Patients

Per the FDA-approved labeling, the standard dosing regimens are:

• Endometrial protection (postmenopausal HRT): 200 mg orally at bedtime for 12 consecutive days per 28-day cycle.
• Secondary amenorrhea: 400 mg orally at bedtime for 10 days.
• Continuous combined HRT (off-label but common): 100 mg orally at bedtime daily.

The 100 mg nightly continuous regimen is the most common in telehealth HRT practice because it eliminates monthly withdrawal bleeding while maintaining endometrial protection. This approach is supported by the 2022 NAMS Hormone Therapy Position Statement and is the regimen most often prescribed through HealthRX New Mexico providers.